Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Inducing Iron Deficiency Dramatically Improves Erythropoiesis and Photosensitivity In Congenital Erythropoietic Porphyria (CEP)

Daniel N. Egan, MD, Zhantao Yang, MD, John Phillips, PhD, Janis L. Abkowitz, MD

Blood (2013) 122 (21): 3442.

https://doi.org/10.1182/blood.V122.21.3442.3442

Published: 2013

Journal Articles

Determination of Rivaroxaban in Urine Samples From Patients Undergoing Elective Hip- and Knee Replacement Surgery Using a Point of Care Method

Job Harenberg, Prof., Dr., Shanshan Du, Sandra Kraemer, Christina Giese, Astrid Schulze, Dr., Roland Kraemer, Prof., Dr.

Blood (2012) 120 (21): 1162.

https://doi.org/10.1182/blood.V120.21.1162.1162

Published: 2012

Journal Articles

Point of Care Method for the Determination of Dabigatran in Urine Samples From Patients On Treatment.

Job Harenberg, Prof., Dr., Sandra Kraemer, Shanshan Du, Christina Giese, Roland Kraemer, Prof., Dr.

Blood (2012) 120 (21): 2270.

https://doi.org/10.1182/blood.V120.21.2270.2270

Published: 2012

Journal Articles

A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload

Hugh Y. Rienhoff, Jr, MD, ip Viprakasit, MD, D, Phil, Lay H. Tay, MBBS, FRCPA, Paul Harmatz, MD, Elliott Vichinsky, MD, Deborah Chirnomas, MD, MPH, Janet Kwiatkowski, MD, Amy E Tapper, PhD, John B Porter, MD, Ellis J. Neufeld, MD, PhD

Blood (2010) 116 (21): 2057.

https://doi.org/10.1182/blood.V116.21.2057.2057

Published: 2010

Journal Articles

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Aneel A. Ashrani, MD, Don A. Gabriel, MD, James L. Gajewski, MD, Nigel S. Key, MD

Blood (2004) 104 (11): 1136.

https://doi.org/10.1182/blood.V104.11.1136.1136

Published: 2004

NARROW

Inducing Iron Deficiency Dramatically Improves Erythropoiesis and Photosensitivity In Congenital Erythropoietic Porphyria (CEP)

Determination of Rivaroxaban in Urine Samples From Patients Undergoing Elective Hip- and Knee Replacement Surgery Using a Point of Care Method

Point of Care Method for the Determination of Dabigatran in Urine Samples From Patients On Treatment.

A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Inducing Iron Deficiency Dramatically Improves Erythropoiesis and Photosensitivity In Congenital Erythropoietic Porphyria (CEP)

Determination of Rivaroxaban in Urine Samples From Patients Undergoing Elective Hip- and Knee Replacement Surgery Using a Point of Care Method

Point of Care Method for the Determination of Dabigatran in Urine Samples From Patients On Treatment.

A Phase 1B Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of FBS0701, a Novel Oral Iron Chelator for the Treatment of Chronic Iron Overload

Pilot Study to Test the Efficacy and Safety of Recombinant Factor VIIa (rFVIIa, NovoSeven™) in the Treatment of Refractory Hemorrhagic Cystitis Following High Dose Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only